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Abstract 
Hibiscus sabdariffa (Malvaceae) is a plant that is widely recognised for its antihypertensive 
properties; however the constituent(s) responsible for this biological activity are presently 
unknown. The aim of this study was to identify the potential compounds that are responsible 
for the vasorelaxant activity of H. sabdariffa.  Thereafter, the mechanisms involved in 
producing the vasorelaxation were investigated. The plant was extracted consecutively with 
hexane, ethyl acetate and methanol. The methanolic extract was subjected to bioassay-guided 
fractionation in order to isolate pure compounds that possessed vasorelaxant activity. The 
vascular effects of the pure compounds were studied on the rat aorta in vitro using myography 
techniques. Hibiscus acid produced a concentration-dependent relaxation of the rat aorta pre-
contracted with either phenylephrine (3 µM) or KCl (60 mM), irrespective of the presence of 
the endothelium. When the tissue was pre-contracted with phenylephrine, the concentration 
required to produce 50% relaxation (IC50), was 0.09 ± 0.01 mg/ml. Hibiscus acid had no effect 
on the phasic contraction induced by phenylephrine in Ca
2+
-free physiological solution; but it 
did affect the component of the contraction that is due to Ca
2+
 influx. In parallel studies, 
garcinia acid, a diastereoisomer of hibiscus acid, was found to have an almost identical 
vasorelaxant effect. The vasorelaxant action of both compounds is most likely due to the 
inhibition of Ca
2+
 influx via voltage-dependent Ca
2+
 channels.  
 
Keywords: Hibiscus sabdariffa; Hibiscus acid; Garcinia acid; Vascular smooth muscle; 
Vasorelaxation; Ca
2+
 channels. 
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1. Introduction 
The red calyces of Hibiscus sabdariffa (H. sabdariffa) (from the family Malvaceae), 
commonly known as Karkade or Red sorrel, have been used in many countries throughout the 
world for their health benefits, particularly as a treatment for hypertension [1-3]. The 
antihypertensive activity of H. sabdariffa has also been studied clinically on patients with 
high blood pressure. These studies have shown that regular daily consumption of hibiscus tea 
caused a clinically significant reduction of approximately 10% in both systolic and diastolic 
blood pressure [4-9]. The magnitude of the effect of hibiscus tea was similar to that obtained 
with the angiotensin converting enzyme inhibitors captopril or lisinopril [5, 6].  
 
A number of in vivo studies have also shown the blood pressure reducing activity of H. 
sabdariffa calyces in hypertensive animals [10-13]. For example, in salt-induced hypertensive 
rats, the aqueous extract of the calyxes lowered both systolic and diastolic blood pressure by 
6 and 7 mmHg, respectively [13]. There have also been a number of in vitro studies 
examining the vasorelaxant effects of the crude extracts of H. sabdariffa. Both aqueous and 
alcohol extracts of hibiscus calyces produced vasorelaxation of the aorta pre-contracted with 
either an adrenoceptor agonist or by depolarization [14-18]. The vasorelaxation was proposed 
to occur through both direct and indirect mechanisms; specifically, by blocking Ca
2+
 entry in 
smooth muscles cells and by stimulation of endothelial-derived relaxing factor respectively 
[17, 18]. These crude extracts have also been shown to have inhibitory effects on the 
contractility of other smooth muscle tissues including the intestine, uterus, and bladder [19, 
20].  
 
Phytochemical studies on the calyces have shown that they contain a number of organic acids 
(hydroxycitric and hibiscus), flavonoids (quercetin, hibiscetin, and gossypetin), and 
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anthocyanins (hibiscin) [3]. However, the compounds which are responsible for the 
antihypertensive activity of H. sabdariffa are still unclear. Therefore, the initial aim of this 
study was to determine which constituent(s) is (are) responsible for this vasorelaxant activity. 
Thereafter, the activity of the pure compound was compared to the vasorelaxant activity of 
the crude methanolic extract of this plant. Subsequent studies were carried out to determine 
the mechanism of action for the vasorelaxant activity of the pure compound on the rat aorta.  
 
2. Materials and Methods 
2.1. Plant materials 
H. sabdariffa (Malvaceae) was provided by Professor John Igoli. It was collected from 
Makurdi in Benue State Nigeria and identified at the Herbarium of the National Institute for 
Pharmaceutical Research and Development (Abuja, Nigeria) by Dr. Jemilat Ibrahim where a 
voucher specimen number NIPRD/H/6972 was deposited. 
 
2.2. Extraction and purification procedures 
We have carried out extraction of the dry calyces in a sequential manner with n-hexane, ethyl 
acetate and methanol (72 h each) using a Soxhlet apparatus. The extract was then fractionated 
using chromatographic techniques, and compound identification was carried out using NMR 
spectroscopy, Mass spectroscopy, and X-ray crystallography [21]. The methanolic crude 
extract of H. sabdariffa calyces was then dissolved in a small volume of methanol and loaded 
to the top of a Sephadex® LH20 column (GE Healthcare, UK). The column was then eluted 
with methanol, yielding 5 subfractions (HS-F1 (6%), HS-F2 (25%), HS-F3 (29%), HS-F4 
(12%), and HS-F5 (6%)). A preliminary bioactivity-led fractionation process was carried out 
to examine the vasorelaxant activity of these subfractions using myography techniques (See 
section 2.4 below), where subfractions (HS-F2, HS-F3, HS-F4, and HS-F5) were found to 
cause vasorelaxation of the aorta. NMR analysis showed that subfractions HS-F2, HS-F3, and 
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HS-F4 are enriched with hibiscus acid and its derivatives, hibiscus acid methyl ester and 
hibiscus acid dimethyl ester, while HS-F5 was almost pure hibiscus acid. This result led us to 
isolate and further purify hibiscus acid, which was prepared in a purity of ≥ 95% (Figure 1A) 
from the calyces as described previously [21]. Hibiscus acid is not commercially available; 
however, it is a chiral compound and its diastereomer, garcinia acid (GA) from (Garcinia 
cambogia) is commercially available, (Figure 1B). Therefore, we have carried out parallel 
studies with garcinia acid, in order to determine if it had a similar vasorelaxant effect to 
hibiscus acid. 
 
 
 
Figure 1: Structures of hibiscus acid (A) and garcinia acid (B).   
 
2.3. Drugs, solvents and chemicals 
(+)-Garcinia acid, R-(-)-phenylephrine hydrochloride, 1, 4-dihydro-2,6-dimethyl-5-nitro-4-
(2-[trifluoromethyl]phenyl)pyridine-3-carboxylic acid methyl ester ((±)-Bay K8644), 
tetraethylammonium chloride, and carbamylcholine chloride were all purchased from Sigma-
Aldrich (Gillingham, UK). 2,5-dimethyl-4-[2-(phenyl methyl) benzoyl]-1H-pyrrole-3-
carboxylic acid methyl ester (FPL 64176) was obtained from Tocris (Abingdon, UK). All 
other reagents and salts used were from either VWR chemicals (Lutterworth, UK), or Sigma-
Aldrich. The crude extract, hibiscus acid, and garcinia acid were prepared as 20 mg/ml stock 
solutions, dissolved in physiological salt solution (PSS), of the following composition (in 
4 
 
mM): NaCl 150, KCl 5.4, glucose 10, HEPES 10, MgCl2 1.2, and CaCl2 1.8, pH adjusted to 
7.4 with NaOH. Solutions of carbamylcholine chloride, tetraethylammonium chloride, and 
phenylephrine (all 100 mM) were prepared using PSS. Bay K8644 and FPL 64176 were 
dissolved in dimethyl sulfoxide (DMSO) as 10 mM stock solutions, and subsequent dilutions 
were made using PSS. In the case of Bay K8644 and FPL 64176, the same dilutions of 
DMSO were used in the control experiments. 
 
2.4. Aorta tissue preparation and wire myography 
In-house bred male and female Sprague-Dawley rats (200-250 g) were sacrificed by cervical 
dislocation, and all studies were carried out in accordance with the guidelines and principles 
for the care and use of laboratory animals at the University of Strathclyde according to 
Schedule 1 of the Animals (Scientific Procedures) Act 1986. The thoracic and abdominal 
aorta was subsequently removed, and placed in cold PSS. Under a dissecting microscope 
(Nikon SMZ645), the aorta was cleaned of any adhering fat and loose connective tissue. The 
aorta was then cut into 4-5 mm long rings and mounted on intraluminal parallel wires; one of 
which was fixed and the other attached to a Grass FT03C force displacement transducer. The 
organ bath (1 ml in volume) was filled with PSS and maintained at 37
o
C whilst being aerated 
with air. A resting tension of 1 g was applied to the tissue and a 1 h equilibration period was 
allowed, with regular reintroduction of fresh PSS and re-adjustment of the 1 g resting tension. 
The contractile response was acquired through a PowerLab 4/30 data acquisition system and 
recorded by Chart (v5.2) software (ADInstruments, Ltd., Oxfordshire, UK). Before 
commencing any experimental protocol the tissue was challenged repeatedly with 40 mM 
KCl until the contractile responses were reproducible.  
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2.5. Effects of the crude methanolic extract of H. sabdariffa on rat aorta 
In order to investigate the vasorelaxant activity, endothelium intact aorta sections were pre-
contracted with PE (3 µM) or KCl (60 mM). Once the contractions were stable, 0.001-1 
mg/ml crude extract of H. sabdariffa was added in a cumulative manner to the tissues pre-
contracted with PE, and 0.01-2 mg/ml crude extract was used in the tissues pre-contracted 
with KCl.  
 
2.6. Effects of hibiscus and garcinia acid on rat aorta 
As per the protocol described above for the crude extract, 0.001-1 mg/ml hibiscus or garcinia 
acid was added in a cumulative manner to the tissues pre-contracted with PE, and 0.01-2 
mg/ml hibiscus or garcinia acid was used in the tissues pre-contracted with KCl.  
 
The majority of the experiments were carried out on endothelium-intact aortas, unless 
otherwise indicated. Confirmation that the endothelium was intact was demonstrated by a 
greater than 70% relaxation in response to carbachol (10 µM), when the aorta was pre-
contracted with PE (3 µM). The influence of the endothelium on the relaxant response of 
either hibiscus or garcinia acid was examined, and this was established by examining their 
effect in denuded preparations. The endothelium was denuded by gently rubbing the luminal 
surface of the aortic ring with a sanded down wooden cocktail stick. The absence of the 
endothelium was confirmed by less than 10% relaxation in response to carbachol (10 µM), in 
aorta pre-contracted with PE (3 µM). 
 
2.7. Role of L-type voltage dependent calcium channels (VDCCs) on hibiscus and 
garcinia acid induced relaxation 
To establish whether hibiscus and garcinia acid produce their relaxation by inhibiting L-type 
voltage dependent calcium channels (VDCCs), their effect on the contractions produced by 
FPL 64176, a benzopyrrole-type agonist of L-type Ca
2+ 
channels [22] or Bay K 8644  [23] 
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was examined. The tissue was initially depolarised with 20 mM KCl for 5 min, to activate 
VDCCs and produce a minimal contractile response. Thereafter, FPL 64176 (30 µM) or Bay 
K 8644 (0.1 µM) was added in order to produce further activation of VDCCs [22, 24]. Once 
the contractile response had stabilised, either hibiscus acid or garcinia acid, was applied in 
concentrations 0.5-1 mg/ml.  
 
2.8. Effect of hibiscus and garcinia acid on the release of intracellular Ca
2+
 
A component of the contractile response to PE involves Ca
2+
 release from the sarcoplasmic 
reticulum (SR), which produces a phasic contractile response [25].  To examine the effect of 
hibiscus and garcinia acid on SR Ca
2+
 release a control contractile response to PE (3 µM) in 
regular PSS was initially obtained.  After a 1 h recovery period, the tissue was exposed to a 
Ca
2+
 free physiological solution containing 1 mM ethylene glycol-bis (β-aminoethyl ether)-
N,N,N',N'-tetraacetic acid (EGTA) for 15 min.  During this period, either vehicle, hibiscus or 
garcinia acid was applied and the tissue was subsequently re-challenged with PE (3 µM). 
 
2.9. Effect of hibiscus and garcinia acid on the influx of extracellular Ca
2+
 
Another component of the contractile response to PE involves Ca
2+
 influx from the 
extracellular space, which produces the sustained (tonic) phase of the contractile response 
[25]. To determine the effect of hibiscus and garcinia acid on the tonic phase of contraction, 
the tissue was exposed to a Ca
2+
 free physiological solution containing 1 mM EGTA for 15 
min, the tissue was then challenged with PE (3 µM) for 5 min to produce the phasic 
contractile response. Thereafter, 1.8 mM Ca
2+ 
(producing a free calcium concentration 0.8 
mM as calculated using the MAXC computer program), was reintroduced to the bath, 
resulting in a tonic contraction Hibiscus or garcinia acid (0.5 mg/ml) was applied during the 
tonic phase of the contraction.  
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2.10. Effect of blocking potassium channels on the relaxant activity of hibiscus and 
garcinia acid 
To establish whether the relaxation to hibiscus or garcinia acid involves the activation of K
+
 
channels, their effect was examined in the presence of the non-selective K
+
 channel blocker 
tetraethyl ammonium chloride (TEA) [26]. The aorta was challenged with PE (3 μM) alone, 
and 0.001 -1 mg/ml hibiscus or garcinia acid was added as described above. Then, and after 1 
h recovery, the aorta was preincubated with 6 mM TEA for 20 min prior to pre-contraction 
with PE (3 μM), and once the contractile response had stabilised, hibiscus or garcinia acid 
was applied to the tissue in a cumulative manner. 
 
3. Statistical analysis 
For the contractile responses, the data were expressed as percentage of maximum contraction 
to either agonists or KCl. Relaxation of the tissues is expressed as the measured tension 
following the addition of hibiscus acid or garcinia acid divided by the steady state tension 
produced by the contractile stimulus being used, x100. Nonlinear regression analysis 
(GraphPad Prism version 7, San Diego, CA, USA) was used for fitting the log concentration-
response curve and determination of the IC50 (concentration required to produce 50% of the 
maximum inhibitory effect) and Imax (the maximum inhibitory effect). One tissue that was 
pre-contracted always served as a control.  All data are presented as mean ± standard error of 
the mean (s.e.m.). The number of observations are expressed in the format of n = N/n where 
N is the number of tissues and n is the number of animals. One-way ANOVA with Tukey's 
multiple comparisons test was used to compare the treatments with control groups, and 
Student’s two-tailed unpaired t-test was applied for statistical comparison of IC50 of different 
groups. P<0.05 was considered to be statistically significant.  
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4. Results 
4.1. Effect of the crude extract of H. sabdariffa on the rat aorta 
The crude methanolic extract of H. sabdariffa produced a concentration-dependent relaxation 
of endothelium-intact rat aorta pre-contracted with PE (3 µM). The IC50 for the crude extract 
was 0.33 ± 0.04 mg/ml (Figure 2A) and the highest concentration tested (1 mg/ml) relaxed 
the tissue by 76 ± 4% (n=12/4). The crude extract also produced a concentration-dependent 
relaxation of the aorta when it was pre-contracted with KCl (60 mM) with an IC50 of 1.5 ± 
0.5 mg/ml; n=16/4. At 1 mg/ml the crude extract produced relaxation of 33 ± 2% when it was 
applied to the aorta pre-contracted with KCl (60 mM), and this was increased to 68 ± 2% at 
the highest concentration examined (2 mg/ml) (Figure 2B). 
 
4.2. Effect of hibiscus and garcinia acid on the rat aorta 
Hibiscus acid caused a concentration-dependent relaxation of the aorta pre-contracted with 
PE (3 μM). The IC50 for hibiscus acid was 0.09 ± 0.01 mg/ml (Figure 3A) in the 
endothelium-intact aorta and the highest concentration tested (1 mg/ml) almost completely 
relaxed the tissue (96 ± 2% relaxation) (n=18/6). The relaxation was maintained for as long 
as hibiscus acid was present, and the tissue showed complete recovery in response to PE after 
washing it out and allowing approximately 60 min for recovery. The time control for these 
experiments showed a slight relaxation (15 ± 4%) in the PE-induced contraction, over the 
time course of the experiment.  
 
When the endothelium was removed, the magnitude of contraction produced by PE increased 
by 27% (n=32/8) compared to that induced in intact aorta.  The relaxant effect of hibiscus 
acid was also examined on endothelium-denuded aorta, where the magnitude of the 
relaxation was similar (89 ± 3%) (n=9/6); but there was a 2-fold shift to the right with regard 
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to the sensitivity to hibiscus acid, yielding an IC50 0.19 ± 0.02 mg/ml (P<0.001 compared to 
endothelium intact) (Figure 3Aii). It was also evident that the lowest concentration of 
hibiscus acid tested (1 mg/ml) had no relaxant effect in the denuded aorta, whereas it caused 
10 ± 2% relaxation in the endothelium intact aorta. In tissues that had been denuded of 
endothelium, which served as a time control, there was a slight increase in the PE-induced 
contraction of 5 ± 9% over the course of the experiment.  
 
Garcinia acid was found to have a similar effect to that of hibiscus acid, showing almost 
complete relaxation in both endothelium intact and denuded aorta. The maximum relaxation 
to garcinia acid was similar irrespective of whether the endothelium was intact (94 ± 2%) or 
denuded (92 ± 2%). However, the IC50 value for garcinia acid was significantly higher in the 
endothelium denuded aorta (0.2 ± 0.02 mg/ml; n=9/6) compared to the endothelium intact 
preparation (0.12 ± 0.01 mg/ml; P < 0.001; n=18/6) (Figure 3B). In comparing the relaxant 
activities of both hibiscus and garcinia acids, there was no significant difference between the 
diastereomers to antagonise the PE-induced contraction. 
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Figure 2: Relaxant effect of the crude methanolic extract of H. sabdariffa (HSM) on the 
rat aorta.  Representative recordings of the effect of HSM on endothelium-intact rat aorta 
pre-contracted with PE (3 µM) (Ai), and KCl (60 mM) (Bi). Summary figures of the 
relaxation due to HSM on the aorta pre-contracted with PE (Aii), and KCl (Bii). The 
relaxation is expressed as a percentage of the initial contraction. Data represent mean ± s.e.m. 
(n=12/4 for PE pre-contraction and n=16/4 for KCl pre-contraction). 
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When the aorta was pre-contacted with KCl (60 mM), hibiscus acid also produced a 
concentration-dependent relaxation. The IC50 was 0.57 ± 0.06 mg/ml; n=12/6 and the highest 
concentration of hibiscus acid examined (2 mg/ml) produced a relaxation of 77 ± 5% (Figure 
4A).  When the endothelium was removed, there was no change in the sensitivity of the aorta 
to hibiscus acid (IC50 was 0.66 ± 0.1 mg/ml; n=6/4) or the magnitude of the relaxation 
obtained at the highest concentration examined (72 ± 6%) (Figure 4A). 
 
Similarly, garcinia acid also relaxed the aorta pre-contracted with KCl (Figure 4B). As with 
hibiscus acid, there was no significant effect of removing the endothelium on the IC50 (0.38 ± 
0.06 mg/ml; n=13/6 for intact and 0.45 ± 0.08 mg/ml; n=10/4 for denuded), or the magnitude 
of the relaxation produced by garcinia acid at the highest concentration tested (77 ± 5% and 
72 ± 5%, respectively). Over the course of these experiments the time control showed a 20 ± 
4% increase in the contractile response to KCl in the endothelium intact preparation and a 22 
± 3% increase in the endothelium-denuded preparation. There was no significant difference 
between hibiscus acid and garcinia acid in their ability to relax the KCl contraction. However, 
the concentration of either hibiscus or garcinia acid that was needed to relax the KCl-induced 
contractions was significantly higher (P < 0.01) than that required to relax the PE-induced 
contractions. 
 
4.3. Relaxant effect of hibiscus or garcinia acid on contraction induced by L- type 
calcium channel activators 
Since hibiscus and garcinia acid relaxed the aorta pre-contracted with KCl, and the 
contraction induced by KCl is primarily dependent on the activation of voltage-dependent 
Ca
2+
 channels (VDCCs), one possible mechanism to explain their vasorelaxant activity is 
through inhibition of VDCCs. To examine this further, the effect of these substances on the 
contractions induced by Ca
2+
 channel activators was examined.  
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Figure 3: Relaxant effect of hibiscus acid and garcinia acid on the rat aorta pre-
contracted with PE. Representative recordings of the effect of HA (Ai) and GA (Bi) on the 
endothelium-intact aorta pre-contracted with PE (3 µM). Relaxant effect of HA (Aii) and GA 
(Bii) on PE-induced contraction of endothelium-intact and endothelium-denuded aortic rings. 
The relaxation is expressed as a percentage of the initial contraction. Data represent mean ± 
s.e.m. (n=18/6 for the intact aortic rings and n=9/6 for the denuded rings). 
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Figure 4: Relaxant effect of hibiscus acid and garcinia acid on the rat aorta pre-
contracted with KCl. Representative recording of the effect of HA (Ai) and GA (Bi) on the 
endothelium-intact aorta pre-contracted with KCl (60 mM). Relaxant effect of HA (Aii) and 
GA (Bii) on KCl-induced contraction of endothelium-intact and endothelium-denuded aortic 
rings. The relaxation is expressed as a percentage of the initial contraction. Values represent 
mean ± s.e.m. (n=12-13/6 for the intact aortic rings and n=6-10/4 for the denuded rings).  
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All the aortas pre-contracted with a low concentration of KCl followed the addition of either 
FPL 64176 or Bay K 8644, showed an oscillatory type of contractile response.  
 
When the aorta was pre-contracted with FPL 64176 (30 M), hibiscus acid (0.5 mg/ml) 
almost completely relaxed the tissue (95 ± 2% relaxation; n=4/4). A similar effect was 
observed when Bay K 8644 (0.1 M) was used to contract the aorta, although in this case a 
higher concentration of hibiscus acid (1 mg/ml) was required to produce a similar degree of 
relaxation (94 ± 4%; n=4/4) (Figure 5). The effect of garcinia acid (0.5 mg/ml) was very 
similar to that of hibiscus acid; producing 94 ± 4% (n=4/4) relaxation of the aorta pre-
contracted with FPL 64176 and requiring a higher concentration (1 mg/ml) to almost 
completely relax the aorta (93 ± 2%; n=4/4) when pre-contracted with Bay K 8644 (Figure 
5). 
 
4.4. Effect of hibiscus and garcinia acid on the phasic and tonic contractions induced by 
PE in the rat aorta 
In the absence of extracellular calcium, the phasic contraction of the aorta induced by PE is 
due to the release of intracellular calcium from intracellular stores [25]. Under Ca
2+
-free 
conditions, PE (3 µM) produced a transient contraction, which was 23 ± 1% of the 
contraction produced by PE in Ca
2+
 containing PSS (Figure 6). Neither hibiscus nor garcinia 
acid (1mg/ml) had any significant effect on the transient contraction to PE in Ca
2+
-free PSS, 
being 16 ± 3% and 15 ± 1% in the presence of the respective acids (n=4/4) (Figure 6).  After 
an initial phasic contraction to PE (3 µM) was obtained in Ca
2+
-free PSS, this developed into 
a sustained contraction following the subsequent re-addition of Ca
2+
 to the PSS. When 
hibiscus acid (Figure 7A) or garcinia acid (Figure 7B) was added during the sustained phase 
of the contraction, it caused a relaxation of 71 ± 3% and 76 ± 5%, respectively (n=4/4) 
(Figure 7C).  
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Figure 5: Relaxant effect of hibiscus acid and garcinia acid, on the rat aorta pre-
contracted with L-type calcium channel activators. Representative recording of the effect 
of HA (0.5-1 mg/ml) on the contraction induced by 30 µM FPL 64176 (A) or 0.1 µM Bay K 
8644 (B). Summary figures of the relaxation due to HA and GA when the aorta was pre-
contracted with either FPL 64176 (C) or Bay K 8644 (D). Data represent mean ± s.e.m. 
(n=4/4).   
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Figure 6: Effect of hibiscus acid and garcinia acid on the phasic component of 
contraction induced by PE (3µM) in the rat aorta. Representative control recording of the 
PE-induced contraction in the presence and absence of extracellular Ca
2+
 (A). The effect of 
HA (1 mg/ml) on the PE-induced contraction in the absence of extracellular Ca
2+
 (B). (C) 
Summary figure showing the effects of HA (0.5 and 1 mg/ml) and GA (1 mg/ml) on the PE-
induced transient contraction of the aorta. Data represent mean ± s.e.m. (n=4/4).  
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Figure 7: Relaxant effect of hibiscus and garcinia acid on the sustained component of 
the PE-induced contraction. Representative recordings showing the effect of hibiscus acid 
(A) and garcinia acid (B) on the tonic component of the PE-induced contraction, following 
the addition of 1.8 mM Ca
2+
. The intracellular store was depleted by the application of PE in 
a Ca
2+
 free medium and the re-addition of Ca
2+
 produced the tonic phase of contraction. (C) 
Summary figure showing the effects of HA and GA (0.5 mg/ml) on the tonic component of 
the PE-induced contraction. Values represent mean ± s.e.m. (n=4/4). 
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4.5. Effect of a potassium channel blocker on the relaxant effect of hibiscus and garcinia 
acid 
Participation of K
+
 channels in the relaxant effect of hibiscus or garcinia acid was also 
examined, using the non-selective potassium channel blocker (TEA). Pre-incubation of the 
aorta with TEA (6 mM) increased the magnitude of PE-induced contraction by 34% (n=13/7) 
when compared to that produced in the absence of TEA.  The IC50 for hibiscus acid induced 
relaxation of the PE pre-contracted aorta was significantly (P<0.05) increased from 0.09 ± 
0.01 mg/ml under control conditions to 0.3 ± 0.04 mg/ml in the presence of TEA, and the 
maximum relaxation was slightly reduced from 95 ± 4% to 82 ± 5%; n=6/6) (Figure 8A). A 
similar effect of TEA was observed when garcinia acid was used as the vasorelaxant. 
Specifically, TEA significantly (P<0.05) increased the IC50 for garcinia acid from 0.13 ± 0.02 
mg/ml to 0.25± 0.03 mg/ml and reduced the maximum relaxation from 93 ± 4 % to 86 ± 2%; 
n=7/6) (Figure 8B). 
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Figure 8: The effect of potassium channel blockade on the relaxation induced by 
hibiscus or garcinia acid on the PE pre-contracted rat aorta. Relaxant effect of HA (A) 
and GA (B) on the PE pre-contracted endothelium-intact aorta in presence and absence of 
TEA (6 mM). The relaxation is expressed as a percentage of the initial contraction. Data 
represent mean ± s.e.m. (n=6/6 for HA and 7/6 for GA). 
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5. Discussion  
There is considerable evidence in the literature that H. sabdariffa has an antihypertensive 
effect and this is further supported by a number of in vitro studies demonstrating a 
vasorelaxant effect of the crude extract of this plant [14-18, 27, 28]. This study demonstrated 
the vasorelaxant activity of the crude methanolic extract of H.sabdariffa calyces on the rat 
aorta, and it was found to be significantly more potent in its relaxant effect when the tissue 
was pre-contracted with PE compared to KCl. These results are in agreement with what has 
been reported previously [17], where the crude methanolic extract at a concentration of 1 
mg/ml produced ~30% relaxation when the aorta was pre-contracted with KCl, and ~80% 
relaxation when it was pre-contracted with PE.  
 
Using a bio-assay guided fractionation process, this study has now shown that hibiscus acid, 
one of the constituents isolated and identified from the calyces of H. sabdariffa has a direct 
vasorelaxant effect on the rat aorta, which may, at least in part, be the constituent responsible 
for the vascular activity of this plant. With regard to the vasorelaxant effect of hibiscus acid, 
it was found to be more potent and efficacious when compared to the activity of the crude 
extract.  The complementary finding that commercially available garcinia acid, which is the 
main organic acid found in Garcinia cambogia (G. cambogia) (Clusiaceae), had a very 
similar effect, provides further support for the notion that hibiscus acid has vasorelaxant 
activity. Both hibiscus and garcinia acid produced a concentration-dependent relaxation of 
the aorta when it was pre-contracted with either PE or KCl. Their effects were fully reversed 
upon their washout indicating that, over the concentration range used, they had no deleterious 
effect on the tissue. Both hibiscus and garcinia acid were found to be significantly more 
potent in their relaxant effect when the tissue was pre-contracted with PE, when compared to 
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pre-contraction with KCl. A similar finding was observed with the crude methanolic extract 
of H. sabdariffa [17].  
 
Removal of the endothelium did not prevent the relaxation of the aorta to either hibiscus or 
garcinia acid in the PE pre-contracted aorta, with a similar degree of relaxation being 
achieved in endothelium intact and endothelium denuded tissues. Whilst this indicates that 
the relaxation to both these substances is endothelium independent there was nevertheless a 
slight rightward shift in the concentration-response curve to both hibiscus and garcinia acid 
after removal of the endothelium. This may indicate a modulatory role of the endothelium in 
the response to either hibiscus or garcinia acid. However, it may also have been a 
consequence of the increased contraction produced by PE when the endothelium was 
removed, a finding that has previously been reported by others [29]. When the aorta was pre-
contracted with KCl, there was no effect of removing the endothelium on the relaxation 
produced by either hibiscus or garcinia acid, and in this case the contractile response to KCl 
was not significantly affected by removal of the endothelium either. It should be noted that 
previous studies with the crude extracts of H. sabdariffa have found that the relaxation is 
significantly affected by removal of the endothelium [15, 17, 18], thus, it is clear that there 
could be additional constituents in the crude extract that are affecting vascular activity.  
 
As both hibiscus and garcinia acid produced relaxation of the rat aorta pre-contracted with 
KCl, one possible explanation for their observed effect is that they are blocking Ca
2+
 
channels. This is because the contraction induced by KCl predominantly involves 
depolarisation of the smooth muscle cell membrane potential and the resultant activation of 
VDCCs. Indeed, the relaxation of this type of contraction is frequently utilised when studying 
the effect of VDCC blockers [24, 30-35]. Further support for this mechanism of action is 
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provided by the studies showing that hibiscus and garcinia relaxed the aorta when it was pre-
contracted with the selective L-type Ca
2+
 channel activator FPL 64176 or Bay K8644 [36, 
37]. The contraction induced by FPL 64176 was completely relaxed by lower concentrations 
of hibiscus or garcinia acid than what was required when Bay K8644 was used to pre-
contract the tissue. A possible explanation for the difference in sensitivity may be related to 
the agonistic properties of FPL 64176 and Bay K8644, as both L-type Ca
2+
 channel activators 
act via a mechanism and site of action that is unique for each [22, 37]. The findings are 
nevertheless consistent with what has been observed previously with classical L-type Ca
2+
 
channel blockers such as nifedipine, diltiazem, and verapamil [22, 38]. Interestingly, these 
selective L-type Ca
2+
 channel activators produced an oscillatory contractile response in the 
aorta, which is similar to what has been previously reported by Auguet et al., (1988). It also 
appeared that hibiscus and garcinia acid were more effective at relaxing the contractions 
induced by the Ca
2+
 channel activators compared to those induced by KCl.  One possible 
reason could be that in these studies, KCl was applied in a hyperosmotic manner and it has 
been shown that a component of this contraction is independent of extracellular Ca
2+
 [39] and 
is somewhat insensitive to Ca
2+
 channel blockers.  This may also explain why neither 
hibiscus nor garcinia acid caused complete relaxation of the aorta when it was pre-contracted 
with KCl. With regard to removal of the endothelium affecting the sensitivity of the aorta to 
hibiscus or garcinia acid, such an effect has also previously been observed with classical Ca
2+
 
channel blockers [40] and this has been attributed to their ability to stimulate the endothelial 
cells to release nitric oxide [41, 42]. 
 
The contraction induced by PE involves both Ca
2+
 release from the sarcoplasmic reticulum 
(SR) and Ca
2+
 influx from the extracellular medium via receptor-operated (ROCCs), and 
VDCCs [43, 44]. Given that neither hibiscus nor garcinia acid affected the phasic contraction 
23 
 
produced by PE in the absence of extracellular Ca
2+
, it seems unlikely that they are affecting 
Ca
2+
 release from the SR. The fact that this initial transient contraction was unaffected by 
either hibiscus or garcinia acid also indicates that these agents are unlikely to be affecting the 
biochemical sequence of events that links the increase in Ca
2+
 concentration to contraction 
[45]. Nevertheless, this is in contrast to what has been reported previously for the crude 
aqueous extract of H. sabdariffa, where there was ~30% reduction in the magnitude of the 
phasic contraction to noradrenaline [27]. Following the phasic response to PE, the re-addition 
of Ca
2+
 produced a sustained contraction that is due to the influx of extracellular Ca
2+
. Both 
hibiscus and garcinia were found to produce relaxation of this tonic component, thereby 
further supporting their inhibitory effect upon Ca
2+
 influx.  
 
While the above findings suggest that hibiscus and garcinia acid are producing vasorelaxation 
through inhibition of VDCCs, it is also possible that activation of K
+
 channels may be 
involved [46]. However, the finding that the non-selective K
+
 channel blocker TEA, did not 
prevent the relaxation to either hibiscus or garcinia acid would argue against them having a 
major role. There was a slight, but significant rightward shift in the concentration-response 
curve to both hibiscus and garcinia acid in the presence of TEA, which reflects a decrease in 
the sensitivity of the aorta to the relaxant effects of both acids. This could be attributed to the 
noted additional contraction produced by TEA itself. The decrease in potassium conductance 
caused by TEA, will result in depolarisation of the smooth muscle cell membrane, thereby 
producing a contraction [47]. Typically when K
+
 channels are responsible for a relaxant 
effect, TEA has been found to reduce the magnitude of the relaxation by >60% [48, 49].  
 
A variety of bioactive constituents have previously been identified in the calyces of H. 
sabdariffa, including phenolic acids, anthocyanins, and flavonoids [3]. However, very few 
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studies have focussed on the pharmacological activities of the constituents identified. 
Hibiscus and garcinia acids are diastereomeric γ-lactones derived from (2S, 3R) and (2S, 3S)-
2-hydroxycitric acid, respectively [50, 51]. Only certain species of plants are known to be 
capable of synthesising hydroxycitric acid [52]; thus, hibiscus and garcinia acids are 
substances which are not found extensively in all plants. Hydroxycitric acid with the absolute 
configuration (2S, 3S), is a major acid component in the fruit rinds of garcinia species, 
including G. cambogia, G. indica, G. Cowa, and G. atroviridis [53-56]. Whereas, 
hydroxycitric acid with the configuration (2S, 3R) is the hibiscus-type enantiomer, which is 
found predominantly in the calyces of H. sabdariffa, H. cannabinus and H. rosa-sinensis [53, 
57, 58].  At present, details of the of the biosynthetic pathway for hydroxycitric acid and how 
it is regulated remain unclear [58]. One hypothesis is that hydroxycitric acid is generated via 
a condensation reaction of oxaloacetate with glycolyl-CoA [58].  
 
Both hibiscus and garcinia acids appear to have similar activity and potency with regard to 
their ability to cause vasorelaxation. This is somewhat unusual, since the majority of 
enantiomers often have unequal pharmacological properties. For example, S(-)-verapamil is 
more potent than the R(+)-verapamil enantiomer in terms of its vasodilatory effect, whilst 
diltiazem is diastereomer with two pair of enantiomers, but only the (2S, 3S) form is 
pharmacologically active [59]. Although rarer, there are nevertheless enantiomers that do 
have equal pharmacological activities; for example the antiarrhythmic flecainide and the 
antidepressant fluoxetine [59, 60]. 
 
6. Conclusion 
This is the first report of a vasorelaxant effect for hibiscus acid, which could potentially 
explain the previously described vascular effects of H. sabdariffa, including its 
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antihypertensive properties [17, 18]. This study has also shown a comparable vasorelaxant 
activity with the diastereomer, garcinia acid. Both acids appear to produce their vasorelaxant 
activity via blockade of the VDCCs in vascular smooth muscle cells, thereby inhibiting the 
influx of extracellular Ca
2+
. Furthermore, this study provides support for the traditional use of 
the extracts or teas of H. sabdariffa as an antihypertensive natural product. 
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